224 related articles for article (PubMed ID: 26558731)
41. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
[TBL] [Abstract][Full Text] [Related]
42. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
43. Factors underlying regression of coronary atheroma with potent statin therapy.
Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
[TBL] [Abstract][Full Text] [Related]
44. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
[TBL] [Abstract][Full Text] [Related]
45. Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).
Nicholls SJ; Borgman M; Nissen SE; Raichlen JS; Ballantyne C; Barter P; Chapman MJ; Erbel R; Libby P
Curr Med Res Opin; 2011 Jun; 27(6):1119-29. PubMed ID: 21446892
[TBL] [Abstract][Full Text] [Related]
46. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
47. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
[TBL] [Abstract][Full Text] [Related]
48. Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.
Toribio M; Fitch KV; Sanchez L; Burdo TH; Williams KC; Sponseller CA; McCurdy Pate M; Aberg JA; Zanni MV; Grinspoon SK
AIDS; 2017 Mar; 31(6):797-806. PubMed ID: 28252528
[TBL] [Abstract][Full Text] [Related]
49. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
Hileman CO; Tangpricha V; Sattar A; McComsey GA
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):539-547. PubMed ID: 28045766
[TBL] [Abstract][Full Text] [Related]
50. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
51. The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.
Brener SJ; Ivanc TB; Hu T
J Invasive Cardiol; 2008 Jun; 20(6):261-5. PubMed ID: 18523316
[TBL] [Abstract][Full Text] [Related]
52. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W
Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
[TBL] [Abstract][Full Text] [Related]
53. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
[TBL] [Abstract][Full Text] [Related]
54. Circulating levels of cardiac troponin T are associated with coronary noncalcified plaque burden in HIV-infected adults: a pilot study.
Foster P; Sokoll L; Li J; Gerstenblith G; Fishman EK; Kickler T; Chen S; Tai H; Lai H; Lai S
Int J STD AIDS; 2019 Mar; 30(3):223-230. PubMed ID: 30381028
[TBL] [Abstract][Full Text] [Related]
55. Statins to improve cardiovascular outcomes in treated HIV infection.
Longenecker CT; Eckard AR; McComsey GA
Curr Opin Infect Dis; 2016 Feb; 29(1):1-9. PubMed ID: 26658651
[TBL] [Abstract][Full Text] [Related]
56. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
Bakker-Arkema RG; Davidson MH; Goldstein RJ; Davignon J; Isaacsohn JL; Weiss SR; Keilson LM; Brown WV; Miller VT; Shurzinske LJ; Black DM
JAMA; 1996 Jan; 275(2):128-33. PubMed ID: 8531308
[TBL] [Abstract][Full Text] [Related]
58. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease.
Suzuki T; Nozawa T; Fujii N; Sobajima M; Ohori T; Shida T; Matsuki A; Kameyama T; Inoue H
Coron Artery Dis; 2011 Aug; 22(5):352-8. PubMed ID: 21494127
[TBL] [Abstract][Full Text] [Related]
59. Low-density lipoprotein and noncalcified coronary plaque composition in patients with newly diagnosed coronary artery disease on computed tomographic angiography.
Cheng VY; Wolak A; Gutstein A; Gransar H; Wong ND; Dey D; Thomson LE; Hayes SW; Friedman JD; Slomka PJ; Berman DS
Am J Cardiol; 2010 Mar; 105(6):761-6. PubMed ID: 20211316
[TBL] [Abstract][Full Text] [Related]
60. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Sullivan D; Olsson AG; Scott R; Kim JB; Xue A; Gebski V; Wasserman SM; Stein EA
JAMA; 2012 Dec; 308(23):2497-506. PubMed ID: 23128163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
